Premier Statement on Appointment of Scott Gottlieb as FDA Commissioner Last Updated: March 20, 2017
Filed under:
Print Friendly, PDF & Email

By Blair Childs, senior vice president of Public Affairs, Premier Inc.

The Premier healthcare alliance commends President Trump for nominating Scott Gottlieb to lead the U.S. FDA. An ardent proponent for free markets and competition, we look forward to working with Mr. Gottlieb and the FDA to speed new drug approval times, revamp regulations to create a more nimble agency and foster healthier markets for pharmaceuticals. We are hopeful that under Mr. Gottleib’s leadership, the FDA can play a critical role in fostering greater competition in the market, which we believe is the best solution to curbing escalating drug costs. Premier looks forward to working closely with the FDA to create solutions that enable a steady pipeline of cures that both save lives and yield savings for providers and patients.

-By Blair Childs, senior vice president of Public Affairs, Premier Inc.